PsoProtect & PsoProtectMe - April 2021 Update

The latest news from these two global psoriasis and COVID-19 registries.

A year on from the start of the COVID-19 pandemic, psoriasis experts Professor Catherine Smith and Dr Satveer Mahil of St John’s Institute of Dermatology in London provide an update on the global PsoProtect and PsoProtectMe registries, which are helping us learn more about the relationship between psoriasis and COVID-19. The update is split into two videos.

Video 1

In the first video, Professor Smith and Dr Mahil answer the following questions:

1. What are PsoProtect and PsoProtectMe? (0:20)
2. Can you share any of the results so far? (1:53)
3. Is there any information yet about whether some of the drugs (for psoriasis) might be safer than others? (3:38)
4. Will the rollout of the COVID-19 vaccines change the focus of PsoProtectMe? (7:15)
5. How can people take part in PsoProtect or PsoProtectMe if they haven’t already? (8:26)

Video 2

The second video addresses the following questions:

1. Where can we read the full results and conclusions from both the PsoProtect and PsoProtectMe projects? (0:19)
2. Are there any findings that haven’t yet been published? (1:12)
3. How do you hope these results will make a difference for people with psoriasis? (3:01)
4. Could you outline the next steps for the projects? (6:22)

Where can I read more about the findings from PsoProtect and PsoProtectMe so far?

In October 2020, the first findings from PsoProtect were published. You can find out more here.

In December 2020, the first publication using PsoProtectMe data revealed new findings on shielding behaviour during the COVID-19 pandemic. You can find out more here.

How can I take part in PsoProtect or PsoProtectMe?

If you have psoriasis yourself, please take the PsoProtectMe survey at www.psoprotectme.org (whether you have had COVID-19 or not).

If you are a healthcare professional, you can report cases of COVID-19 in your patients with psoriasis at www.psoprotect.org.